Mitochondrial-targeted antioxidants and oxidative stress: A proteomic prospective study

Current Pharmaceutical Design

Volumn 15, Issue 26, 2009, Pages 3052-3062

  Rocha, Milagros ^a,b   Esplugues, Juan V ^b   Hernández Mijares, Antonio ^a,c   Víctor, Víctor M ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Antioxidant; Cardiovascular disease; Free radicals; Mitochondria; Oxidative stress; Proteomics

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; FLUPIRTINE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL DNA; NITRIC OXIDE; PROTEOME; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME; TROLOX C; TROPONIN; UBIQUINONE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DEATH; CELL FUNCTION; CELL METABOLISM; ELECTROPHORESIS; ENERGY YIELD; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHOBICITY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOME; MITOCHONDRIAL DNA DISORDER; MITOCHONDRION; OXIDATIVE STRESS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEOMICS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; FREE RADICALS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PROTEOMICS;

EID: 70449431374     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789058138     Document Type: Review

References (105)

1. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol 1989; 18: 20-28
2. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-867
3. Tuomisto TT, Yla-Herttuala S. What have we learnt about microarray analyses of atherogenesis?. Curr Opin Lipidol 2005; 16: 201-205
4. Bijnens AP, Lutgens E, Ayoubi T, Kuiper J, Horrevoets AJ, Daemen MJ. Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol 2006; 26: 1226-1235
5. Gutteridge JM, Mitchell J. Redox imbalance in critical ill. Br Med Bull 1999; 55: 49-75.
6. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828
7. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906 (Pubitemid 30225269)
8. Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet 2005; 6: 287-298
9. Tuomisto TT, Binder BR, Yla-Herttuala S. Genetics, genomics and proteomics in atherosclerosis research. Ann Med 2005; 37: 323-332 (Pubitemid 41379839)
10. Green D, Kroemer G. The central executioners of apoptosis: caspases or mitochondria?. Trends Cell Biol 1998; 8: 267-271 (Pubitemid 28310224)
11. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999; 26: 463-471 (Pubitemid 29013479)
12. Victor VM, Rocha M, De la Fuente M. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 2003; 37: 919-929 (Pubitemid 37221024)
13. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004; 4: 327-347 (Pubitemid 38375967)
14. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005; 11: 3141-3158 (Pubitemid 41149930)
15. Kagan VE, Serbinova EA, Stoyanovsky DA, Khwaja S, Packer L. Assay of ubiquinones and ubiquinols as antioxidants. Methods Enzymol 1994; 234: 343-354
16. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 2006; 1762: 256-265
17. White MY, Edwards AV, Cordwell JJ, Van Eyk JE. Mitochondria: a mirror into cellular dysfunction in heart disease. Proteomics Clin Appl 2008; 2:845-861 (Pubitemid 351943766)
18. Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 2006; 1762: 164-180 (Pubitemid 43006023)
19. Collins TJ, Berridge MJ, Lipp P, Bootman MD. Mitochondria are morphologically and functionally heterogeneous within cells. EMBO J 2002; 21: 1616-1627 (Pubitemid 34614618)
20. Forner F, Foster LJ, Campanaro S, Valle G, Mann M. Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics 2006; 5: 608-619
21. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656-2668
22. Houstek J, Pickova A, Vojtiskova A, Mracek T, Pecina P, Jesina P. Mitochondrial diseases and genetic defects of ATP synthase. Biochim Biophys Acta 2006; 1757: 1400-1405 (Pubitemid 44442111)
23. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287: 817-833
24. Stavrovskaya IG, Kristal BS. The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?. Free Radic Biol Med 2005; 38: 687-697
25. Di Lisa F, Bernardi P. Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res 2005; 66: 222-232
26. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-519 (Pubitemid 27053665)
27. Reaume AG, Elliott JL, Hoffman EK, Kowal NW, Ferrante RJ, Siwek DF, et al. Motor neurons in Cu/Zn superoxide dismutasedeficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43-47
28. Ramachandran A, Moellering DR, Ceaser E, Shiva S, Xu J, Darley- Usmar V. Inhibition of mitochondrial protein synthesis results in increased endothelial cell susceptibility to nitric oxide-induced apoptosis. Proc Natl Acad Sci USA 2002; 99: 6643-6648 (Pubitemid 34526186)
29. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002; 105: 849-854 (Pubitemid 34174926)
30. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1 alpha. Science 2003; 302:1975-1978 (Pubitemid 37523507)
31. Devary Y, Rosette C, DiDonato JA, Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 1993; 261: 1442-1445 (Pubitemid 23334264)
32. Schulze-Osthoff K, Beyaert R, Vandervoorde V, Haegeman G, Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993; 12: 3095-3104. (Pubitemid 23232740)
33. Lane P, Hao G, Gross SS. S-nitrosylation is emerging as a specific fundamental posttranslational protein modification: head to head comparison with O-phosphorylation. Sci STKE 2001; 2001(86): RE1 (Review).
34. Poole LB, Karplus PA, Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 2004; 44: 325-347 (Pubitemid 38263844)
35. Barford D. The role of cysteine residues as redox-sensitive regulatory switches. Curr Opin Struct Biol 2004; 14: 679-686 (Pubitemid 39592578)
36. VanMontfort RL, Congreve M, Tisi D, Carr R, Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003; 423: 773-777 (Pubitemid 36735702)
37. Takeishi Y, Jalili T, Ball NA, Walsh RA. Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 1999; 85: 264-271 (Pubitemid 29377298)
38. Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220-1224
39. Squier TC. Oxidative stress and protein aggregation during biological aging. Exp Gerontol 2001; 36: 1539-1550 (Pubitemid 32768730)
40. Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA 1992; 89: 4544-4548
41. Beckman JS. Protein tyrosine nitration and peroxynitrite. FASEB J 2002; 16: 1144.
42. Levine RL, Stadtman ER. Oxidative modification of proteins during aging. Exp Gerontol 2001; 36: 1495-1502
43. Requena JR, Chao CC, Levine RL, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001; 98: 69-74.
44. Stadtman ER, Moskovitz J, Berlett BS, Levine RL. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem 2002; 234-235: 3-9. (Pubitemid 34777836)
45. Von Kleist-Retzow JC, Schauseil-Zipf U, Michalk DV, Kunz WS. Mitochondrial diseases - an expanding spectrum of disorders and affected genes. Exp Physiol 2003; 88: 155-166 (Pubitemid 36157274)
46. Murphy MP, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 2000; 41: 235-250
47. Staal FJ, Anderson MT, Staal GE, Herzenberq LA, Gitler C, Herzenberg LA. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci USA 1994; 91: 3619-3622 (Pubitemid 24984875)
48. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488
49. Smith MA, Richey PL, Taneda S, Kutty RK, Sayre LM, Monnier VM, et al. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann NY Acad Sci 1994; 738: 447-454
50. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000; 32: 307-326 (Pubitemid 32001909)
51. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 2005; 24: 55-99. (Pubitemid 40146422)
52. Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci 2000; 899: 191-208.
53. Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006; 545: 39-50. (Pubitemid 44215876)
54. Rabilloud T, Ed. Proteome Research: Two-Dimensional Gel Electrophoresis and Identification Methods. New York, NY: Springer 2000.
55. White MY, Cordwell SJ, McCarron HC, Prasan AM, Craft G, Hambly BD, et al. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics 2005; 5: 1395-1410 (Pubitemid 40503055)
56. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102: 13807-13812
57. Mateos-Caceres PJ, Garcia-Mendez A, Lopez Farre A, Macaya C, Núñez A, Gómez J, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004; 44: 1578-1583 (Pubitemid 39369788)
58. Gramolini AO, Kislinger T, Liu PP, MacLennan DH, Emili A. Analyzing the cardiac muscle proteome by liquid chromatography-mass spectrometry-based expression proteomics. Methods Mol Biol 2007; 357: 15-31.
59. Buscemi N, Murray C, Doherty-Kirby A, Lajoie G, Sussman, MA, Van Eyk JE. Myocardial subproteomic analysis of a constitutively active Rac1- expressing transgenic mouse with lethal myocardial hypertrophy. Am J Physiol Heart Circ Physiol 2005; 289: H2325-33.
60. Sawicki G, Jugdutt BI. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics 2004; 4: 2195-2202
61. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. American Heart Association. Circulation 1994; 89: 2462-2478
62. Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q. Vascular proteomics: linking proteomic and metabolic changes. Proteomics 2004; 4: 3751-3761
63. Stastny J, Fosslien E, Robertson AL Jr. Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis 1986; 60: 131-139
64. Bruneel A, Labas V, Mailloux A, Sharma S, Vinh J, Vaubourdolle M, et al. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003; 3: 714-723
65. Stastny JJ, Fosslien E. Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. Exp Mol Pathol 1992; 57: 205-214
66. Song J, Stastny J, Fosslien E, Robertson AL Jr. Effect of aging on human aortic protein composition: II. Two-dimensional polyacrylamide gel electrophoretic analysis. Exp Mol Pathol 1985; 43: 297-304.
67. You SA, Archacki SR, Angheloiu G, Moravec CS, Rao S, Kinter M, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 2003; 13: 25-30.
68. Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC. Proteomic analysis of high-density lipoprotein. Proteomics 2006; 6: 721-730
69. Jang WG, Kim HS, Park KG, Park YB, Yoon KH, Han SW, et al. Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics 2004; 4: 3383-3393
70. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005; 5: 551-565 (Pubitemid 40262072)
71. Lehr HA, Sagban TA, Ihling C, Zähringer U, Hungerer KD, Blumrich M, et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 2001; 104: 914-920
72. Khovidhunkit W, Duchateau PN, Medzihradszky KF, Moser AH, Naya-Vigne J, Shigenaga JK, et al. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 2004; 176: 37-44. (Pubitemid 39078642)
73. Duran MC, Mas S, Martin-Ventura JL, Meilhac O, Michel JB, Gallego-Delgado J, et al., Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 2003; 3: 973-978
74. Fach EM, Garulacan LA, Gao J, Xiao Q, Storm SM, Dubaquie YP, et al. In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics 2004; 3: 1200-1210
75. Ping P. Identification of novel signaling complexes by functional proteomics. Circ Res 2003; 93: 595-603. (Pubitemid 37222155)
76. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, et al. Nucleolar proteome dynamics. Nature 2005; 433: 77-83.
77. Stanley BA, Gundry RL, Cotter RJ, Van Eyk JE. Heart disease, clinical proteomics and mass spectrometry. Dis Markers 2004; 20: 167-178 (Pubitemid 39314347)
78. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665-3685 (Pubitemid 39657447)
79. Ramachandran N, Hainsworth E, Bhullar B, Eisenstein S, Rosen B, Lau AY, et al. Self-assembling protein microarrays. Science 2004; 305: 86-90.
80. Kricka LJ, Master SR. Validation and quality control of protein microarray-based analytical methods. Methods Mol Med 2005; 114: 233-255
81. Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002; 54: 101-127
82. Jauslin ML, Meier T, Smith RA, Murphy MP. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 2003; 17: 1972-1974
83. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, et al. Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000; 289: 1567-1569 (Pubitemid 30677478)
84. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 846-851 (Pubitemid 29072146)
85. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, et al. Lifespan extension and rescue of spongiform encephalopaty in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 2001; 21: 8348-8353 (Pubitemid 33051432)
86. Osborne NN, Schwarz M, Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest Ophthalmol Vis Sci 1996; 37: 274-280 (Pubitemid 26057053)
87. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000; 290: 985-989 (Pubitemid 30813267)
88. Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, et al. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem 2000; 275: 26096-26101 (Pubitemid 30676652)
89. Murray J, Zhang B, Taylor SW, Oglesbee D, Fahy E, Marusich MF, et al. The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurification. J Biol Chem 2003; 278: 13619-13622 (Pubitemid 36799895)
90. Schilling B, Srinivas B, Row RH, Andersen JA, Gibson BW. Determination of glutathione depletion-dependent thiol oxidation of mitochondrial complex I upon oxidative stress using stable isotope alkylating reagents. In Proceedings of the 51st Annual Meeting of the American Society for Mass Spectrometry. Canada: Montreal 2003.
91. Gipy SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitaive analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17: 994-999 (Pubitemid 29474856)
92. Sethuraman M, McComb ME, Heibeck T, Costello CE, Cohen RA. Isotope-coded affinity tag (ICAT) approach to identify and quantify oxidant-sensitive protein thiols. Mol Cell Proteomics 2004; 3: 273-278 (Pubitemid 38714283)
93. Coulter CV, Kelso GF, Lin TK, Smith RA, Murphy MP. Mitochondrially targeted antioxidants and thiol reagents. Free Radic Biol Med 2000; 28: 1547-1554
94. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 2003; 278: 19603-19610 (Pubitemid 36799143)
95. Sarver A, Scheffler NK, Shetlar MD, Gibson BW. Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 2001; 12: 439-448 (Pubitemid 34546613)
96. Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 2003; 278: 37223-37230 (Pubitemid 37175238)
97. Ahmed N, Thornalley PJ. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular protein by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 2003; 31: 1417-1422 (Pubitemid 38030990)
98. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478 (Pubitemid 20279989)
99. Soreghan BA, Yang F, Thomas SN, Hsu J, Yang AJ. High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain. Pharm Res 2003; 20: 1713-1720 (Pubitemid 37449442)
100. Yin X, Mayr M, Xiao Q, Wang W, Xu Q. Proteomic analysis reveals higher demand for antioxidant protection in embryonic stem cell-derived smooth muscle cells. Proteomics 2006; 6: 6437-6446 (Pubitemid 46048384)
101. Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 2004; 4: 3751-3761 (Pubitemid 39657452)
102. McGregor E, Kempster L, Wait R, Welson SY, Gosling M, Dunn MJ, et al. Identification and mapping of human saphenous vein medial smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. Proteomics 2001; 1: 1405-1414 (Pubitemid 33587896)
103. Mocchegiani E, Malavolta M, Muti E, Costarelli L, Cipriano C, Piacenza F, et al. Zinc, metallothioneins and longevity: interrelationships with niacin and selenium. Curr Pharm Des 2008; 14(26): 2719-2732
104. Pulitano C, Aldrighetti L. The protective role of steroids in ischemia- reperfusion injury of the liver. Curr Pharm Des 2008; 14(5): 496-503.
105. Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in drug discovery. J Pharm Sci 2008; 97(2): 654-690